866-997-4948(US-Canada Toll Free)

United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 97 Pages

Notes:
Sales, means the sales volume of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
Revenue, means the sales value of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs

This report studies sales (consumption) of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
GlaxoSmithKline Plc
Helsinn Group
Heron Therapeutics
Merck & Co Inc
Tesaro
...

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Corticosteroids
Serotonin Antagonists
Dopamine Antagonists
NK-1 Inhibitors
Cannabinoids
Motion Sickness Treatments
Anti-Anxiety Drugs
Other
Split by applications, this report focuses on sales, market share and growth rate of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in each application, can be divided into
High Emetic Risk Intravenous Chemotherapy
Moderate Emetic Risk Intravenous Chemotherapy
Low and Minimal Emetic Risk Intravenous Chemotherapy
Other

Table of Contents

United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Report 2017
1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Overview
1.1 Product Overview and Scope of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
1.2 Classification of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
1.2.1 Corticosteroids
1.2.2 Serotonin Antagonists
1.2.3 Dopamine Antagonists
1.2.4 NK-1 Inhibitors
1.2.5 Cannabinoids
1.2.6 Motion Sickness Treatments
1.2.7 Anti-Anxiety Drugs
1.2.8 Other
1.3 Application of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
1.3.1 High Emetic Risk Intravenous Chemotherapy
1.3.2 Moderate Emetic Risk Intravenous Chemotherapy
1.3.3 Low and Minimal Emetic Risk Intravenous Chemotherapy
1.3.4 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs (2012-2022)
1.4.1 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue and Growth Rate (2012-2022)

2 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Competition by Manufacturers
2.1 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Average Price by Manufactures (2015 and 2016)
2.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Competitive Situation and Trends
2.4.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Concentration Rate
2.4.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales and Market Share by States (2012-2017)
3.2 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price by States (2012-2017)

4 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2012-2017)
4.4 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate by Type (2012-2017)

5 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Profiles/Analysis
6.1 GlaxoSmithKline Plc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Helsinn Group
6.2.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Heron Therapeutics
6.3.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merck & Co Inc
6.4.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Tesaro
6.5.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
...

7 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Cost Analysis
7.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Forecast (2017-2022)
11.1 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Type (2017-2022)
11.3 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Application (2017-2022)
11.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
Table Classification of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
Figure United States Sales Market Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Type in 2015
Figure Corticosteroids Picture
Figure Serotonin Antagonists Picture
Figure Dopamine Antagonists Picture
Figure NK-1 Inhibitors Picture
Figure Cannabinoids Picture
Figure Motion Sickness Treatments Picture
Figure Anti-Anxiety Drugs Picture
Figure Other Picture
Table Application of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
Figure United States Sales Market Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Application in 2015
Figure High Emetic Risk Intravenous Chemotherapy Examples
Figure Moderate Emetic Risk Intravenous Chemotherapy Examples
Figure Low and Minimal Emetic Risk Intravenous Chemotherapy Examples
Figure Other Examples
Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales and Growth Rate (2012-2022)
Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue and Growth Rate (2012-2022)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Manufacturers
Figure 2016 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Manufacturers
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers
Table 2016 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers
Table United States Market Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Average Price of Key Manufacturers in 2015
Figure Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Share of Top 3 Manufacturers
Figure Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Share of Top 5 Manufacturers
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by States (2012-2017)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Share by States (2012-2017)
Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by States in 2015
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by States (2012-2017)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by States (2012-2017)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price by States (2012-2017)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2012-2017)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Type (2012-2017)
Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2015
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by Type (2012-2017)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Type (2012-2017)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2012-2017)
Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate by Type (2012-2017)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2012-2017)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2012-2017)
Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2015
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share (2012-2017)
Table Helsinn Group Basic Information List
Table Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share (2012-2017)
Table Heron Therapeutics Basic Information List
Table Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share (2012-2017)
Table Merck & Co Inc Basic Information List
Table Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share (2012-2017)
Table Tesaro Basic Information List
Table Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
Figure Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
Figure Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Major Manufacturers in 2015
Table Major Buyers of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
Table Distributors/Traders List
Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Production Forecast by Type (2017-2022)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Application (2017-2022)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by States (2017-2022)
Table United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *